Literature DB >> 26312935

Evaluation of the reference value for the Montenegro skin test.

Cissiara Manetti Skraba1, Tatiane França Perles de Mello1, Raíssa Bocchi Pedroso1, Érika Cristina Ferreira1, Izabel Galhardo Demarchi1, Sandra Mara Alessi Aristides2, Maria Valdrinez Campana Lonardoni2, Thaís Gomes Verzignassi Silveira2.   

Abstract

INTRODUCTION: The Montenegro skin test (MST) has good clinical applicability and low cost for the diagnosis of American tegumentary leishmaniasis (ATL). However, no studies have validated the reference value (5mm) typically used to discriminate positive and negative results. We investigated MST results and evaluated its performance using different cut-off points.
METHODS: The results of laboratory tests for 4,256 patients with suspected ATL were analyzed, and 1,182 individuals were found to fulfill the established criteria. Two groups were formed. The positive cutaneous leishmaniasis (PCL) group included patients with skin lesions and positive direct search for parasites (DS) results. The negative cutaneous leishmaniasis (NCL) group included patients with skin lesions with evolution up to 2 months, negative DS results, and negative indirect immunofluorescence assay results who were residents of urban areas that were reported to be probable sites of infection at domiciles and peridomiciles.
RESULTS: The PCL and NCL groups included 769 and 413 individuals, respectively. The mean ± standard deviation MST in the PCL group was 12.62 ± 5.91mm [95% confidence interval (CI): 12.20-13.04], and that in the NCL group was 1.43 ± 2.17mm (95% CI: 1.23-1.63). Receiver-operating characteristic curve analysis indicated 97.4% sensitivity and 93.9% specificity for a cut-off of 5mm and 95.8% sensitivity and 97.1% specificity for a cut-off of 6mm.
CONCLUSIONS: Either 5mm or 6mm could be used as the cut-off value for diagnosing ATL, as both values had high sensitivity and specificity.

Entities:  

Mesh:

Year:  2015        PMID: 26312935     DOI: 10.1590/0037-8682-0067-2015

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  9 in total

1.  Assessment of a Leishmaniasis Reporting System in Tropical Bolivia Using the Capture-Recapture Method.

Authors:  Daniel Eid; Miguel Guzman-Rivero; Ernesto Rojas; Isabel Goicolea; Anna-Karin Hurtig; Daniel Illanes; Miguel San Sebastian
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

2.  The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14.

Authors:  Priscila L Dos Santos; Fabrícia A de Oliveira; Micheli Luize B Santos; Luana Celina S Cunha; Michelle T B Lino; Michelle F S de Oliveira; Manuela O M Bomfim; Angela Maria Silva; Tatiana R de Moura; Amélia R de Jesus; Malcolm S Duthie; Steven G Reed; Roque P de Almeida
Journal:  PLoS Negl Trop Dis       Date:  2016-01-27

Review 3.  Potential biomarkers of immune protection in human leishmaniasis.

Authors:  Mahmoud Nateghi Rostami; Ali Khamesipour
Journal:  Med Microbiol Immunol       Date:  2021-05-02       Impact factor: 3.402

4.  Reappraisal of Leishmanin Skin Test (LST) in the management of American Cutaneous Leishmaniasis: A retrospective analysis from a reference center in Argentina.

Authors:  Alejandro Javier Krolewiecki; Maria Cristina Almazan; Marcelo Quipildor; Marisa Juarez; Jose Fernando Gil; Marco Espinosa; Maria Canabire; Silvana Pamela Cajal
Journal:  PLoS Negl Trop Dis       Date:  2017-10-05

5.  Reactivation of cutaneous and mucocutaneous tegumentary leishmaniasis in rheumatoid arthritis patients: an emerging problem?

Authors:  Regina Maia de Souza; Heitor Franco de Andrade; Maria Irma Seixas Duarte; Lucia Maria Almeida Braz; Armando de Oliveira Schubach; Fátima Conceição Silva; Valdir Sabbaga Amato
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-03       Impact factor: 1.846

6.  Treatment of cutaneous leishmaniasis with thermotherapy in Brazil: an efficacy and safety study.

Authors:  Sheila Viana Castelo Branco Gonçalves; Carlos Henrique Nery Costa
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

7.  Tegumentary leishmaniasis diagnosis: what happened with MST (Montenegro Skin Test) in Brazil?

Authors:  Lucia Maria Almeida Braz
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-03-11       Impact factor: 1.846

Review 8.  A review of the leishmanin skin test: A neglected test for a neglected disease.

Authors:  Jessica Carstens-Kass; Kayla Paulini; Patrick Lypaczewski; Greg Matlashewski
Journal:  PLoS Negl Trop Dis       Date:  2021-07-22

9.  Risk factors for cutaneous leishmaniasis in the rainforest of Bolivia: a cross-sectional study.

Authors:  Daniel Eid; Miguel Guzman-Rivero; Ernesto Rojas; Isabel Goicolea; Anna-Karin Hurtig; Daniel Illanes; Miguel San Sebastian
Journal:  Trop Med Health       Date:  2018-04-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.